HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The influence of the new beta sympathicolytic agent carazolol on sympathicotonic false regulation (author's transl)].

Abstract
In 18 patients with tachycardia at rest the effect of treatment with the beta sympathicolytic agent Carazolol was investigated, using Schellong's test, venous occlusion plethysmography, ECG and a questionaire evaluating concomitant effects. A significant reduction in heart rate (about 20 percent) as well as a decrease in systolic blood pressure were observed. No further therapeutical effect was seen during long term treatment. There wer no significant influences on venous occlusion plethysmography and ECG. The patients reported a considerable improvement of their heart complaints.
AuthorsD Sievers
JournalMedizinische Klinik (Med Klin) Vol. 72 Issue 28-29 Pg. 1209-11 (Jul 15 1977) ISSN: 0025-8458 [Print] Germany
Vernacular TitleDie Wirkung des neuen Betarezeptorenblockers Carazolol bei sympathikotoner Fehlregulation des Kreislaufs.
PMID887047 (Publication Type: Journal Article)
Chemical References
  • Carbazoles
  • Propanolamines
  • carazolol
Topics
  • Adolescent
  • Adult
  • Blood Pressure
  • Carbazoles (therapeutic use)
  • Cardiovascular Diseases (diagnosis, drug therapy)
  • Electrocardiography
  • Humans
  • Male
  • Middle Aged
  • Plethysmography
  • Propanolamines (therapeutic use)
  • Pulse
  • Sympathetic Nervous System
  • Tachycardia (diagnosis, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: